Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
Harrington Discovery Institute and the American Society for Clinical Investigation seek nominations to recognize an outstanding achievement by a physician-scientist
Continue Reading
Scientists have created the largest molecular map of autism, identifying over 1,800 protein interactions that could revolutionize future treatment strategies.
Continue Reading
Published in Science Magazine featuring Bowen Li, PhD, University of Toronto, 2024 Oxford-Harrington Rare Disease...
Continue Reading
The American Society for Clinical Investigation (ASCI) honors Arul M. Chinnaiyan, MD, PhD, and Charles L. Sawyers, MD, with the 2026 ASCI/Harrington Prize for Innovation in Medicine.
Continue ReadingIn addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See All DiscoveriesBy concentrating philanthropic, scientific, and business development resources during the high-risk stages of drug development, Harrington ‘de-risks’ therapeutic candidates and positions them for further investment and commercialization.
Learn More